跳至主要内容
临床试验/ACTRN12623000850673
ACTRN12623000850673招募中Unknown

Effectiveness of a conversational Artificial Intelligence program to support patients with atrial fibrillation (AF) in optimising quality of life: the Conversational HeAlth supporT for AF Self-Management (CHAT-AF-S) multi-centre randomised controlled trial

niversity of Sydney0 个研究点目标入组 416 人开始时间: 2023年8月8日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
416

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients will be eligible to participate if they (1) are 18 years old or above, (2) have a documented diagnosis of AF, (3) have a mobile phone that is able to receive calls, (4) are able to receive text messages and open weblinks embedded in them, and (5) are competent with English, as ascertained by the study researcher.

排除标准

  • Participants will be excluded from the study if they (1) are on concurrent active intervention studies focused on atrial fibrillation education and self-management (2) have a concomitant illness, physical impairment or mental condition which in the opinion of the study team/primary care physician could interfere with the conduct of the study including outcome assessment (e.g. hearing impairment not corrected by a digital hearing aid), (3) are pregnant, (4) have a medical illness with anticipated life expectancy of < 3 years, and (5) are unable or unwilling to provide written consent.

研究者

相似试验